Registry of patients with multiple myeloma in Turkey
Multiple Myeloma Patient Registry - Prospective National Multi Center Prospective Study
This study is creating a national registry to collect information from about 1,000 patients with multiple myeloma in Turkey to better understand their treatment and quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Turkish Hematology Association Academic / other |
| Locations | 1 site (Istanbul) |
| Trial ID | NCT04143932 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a national registry for patients diagnosed with multiple myeloma across approximately 40 centers in Turkey. The study will recruit around 1000 patients who will be followed up until the study concludes. Data collected will include laboratory results, treatment protocols, and patient responses, assessed using specific quality of life questionnaires. The goal is to gather comprehensive information on the management and outcomes of multiple myeloma in the Turkish population.
Who should consider this trial
Good fit: Ideal candidates for this study are adults diagnosed with multiple myeloma who have received no more than two lines of therapy.
Not a fit: Patients under 18 years old will not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could improve understanding of multiple myeloma treatment outcomes and enhance patient care in Turkey.
How similar studies have performed: Other similar registries have shown success in improving treatment protocols and patient outcomes in various regions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed as multiple myeloma * Patients signed informed consent form * Patients received no more then 2 lines of therapy Exclusion Criteria: * Patients below 18 years old
Where this trial is running
Istanbul
- Medipol University — Istanbul, Turkey (Recruiting)
Study contacts
- Principal investigator: Omur Gokmen Sevindik, Assoc. Prof. — Medipol University Hospital
- Study coordinator: Omur Gokmen Sevindik, Assoc. Prof.
- Email: omurgok17@hotmail.com
- Phone: +905427870708
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.